XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
  Breast
  Skin
  Blood
  Prostate
  Liver
  Colon
  Thyroid
  Endometrial
  Brain
  Therapy
  Risk Factors
  Esophageal
  Bladder
  Lung
  Rectal Cancer
  Pancreatic Cancer
  Bone Cancer
  Cervical Cancer
  Testicular Cancer
  Gastric Cancer
  Ovarian Cancer
  Nerve Tissue
  Renal Cell Carcinoma
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Breast Channel
subscribe to Breast newsletter

Latest Research : Cancer : Breast

   DISCUSS   |   EMAIL   |   PRINT
Cancer Screening Useful in Breast Reduction Surgery Patients
Sep 28, 2005, 13:07, Reviewed by: Dr.

�We are in a time in medicine when cost is an important factor. Pressure from insurance companies and general administrators often force physicians to consider the cost of care when treating a patient�

 
Twelve percent of breast reduction patients may have abnormal pathologies placing them at an increased risk of developing breast cancer, according to a study presented today at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2005 conference in Chicago. In addition, the authors found it more cost effective to screen breast reduction patients of all ages, not just those over 40, the age when routine screening mammography is recommended.

Plastic surgeons who perform breast reductions routinely have the removed tissue tested for abnormalities. While the screening of each patient may detect breast cancer early, it also escalates the overall cost.

�We are in a time in medicine when cost is an important factor. Pressure from insurance companies and general administrators often force physicians to consider the cost of care when treating a patient,� said Kristin Stueber, MD, ASPS Member Surgeon and co-author of the study. �However, detecting breast cancer as early as possible reduces treatment costs and saves lives. In the end, we found that although it may cost more up-front to screen each breast reduction patient for cancer, we saved money and helped patients to get treatment sooner.�

In the study, 12 percent of the 300 patients tested, ranging from 14 to 73 years old, had abnormal pathology reports indicating either a premalignant lesion or a lesion that puts the patient at an increased risk of developing breast cancer. Of those with an abnormal outcome, 28 percent were deemed moderate or high risk, placing them at a significantly higher threat than the general population for developing breast cancer. Two of the 10 high-risk patients were less than 40 years old. Any patient with an abnormal test was referred to a comprehensive breast center to watch for indications of breast cancer.

Based on the study of 300 patients where pathologic examination of each patient�s breast tissue was $381.72, there could have been a savings of $81,688 by only testing women above the age of 40, who equaled less than 29 percent of the patients. However, selective testing would have missed two potential cases of breast cancer.

�If we were to limit our pathologic examination of breast tissue to breast reduction patients older than 40, we would fail to identify 20 percent of moderate to high risk pathology, which is simply not an acceptable risk,� said Dr. Stueber. �Besides the potential cost savings in testing, the cost for treating a cancer patient down the road is certainly more than any savings we could produce in the short term.�

More than 105,500 women had breast reduction surgery in 2004, according to ASPS statistics. Applying the findings of this study to last year�s numbers, if the medical community only tested women above the age of 40, it would have missed 633 cases of moderate to high risk breast cancer.

Breast cancer is 90 percent curable when discovered early. An estimated 211,240 new invasive cases of breast cancer are expected to occur in 2005 among women in the United States, according to the American Cancer Society. This year, more than 40,000 women are expected to die from the disease.
 

- This study was pesented on Sunday, Sept. 25, McCormick Place Lakeside Center, Chicago.
 

www.plasticsurgery.org

 
Subscribe to Breast Newsletter
E-mail Address:

 

The American Society of Plastic Surgeons is the largest organization of board-certified plastic surgeons in the world. With more than 5,800 Member Surgeons, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.

Related Breast News

Breast cancer chemotherapy may deterioration in cognitive function
Elderly Breast Cancer Patients May Be Under-Diagnosed And Under-Treated
Tissue Geometry Plays Crucial Role in Breast Cell Invasion
Ethnic variations in hormone levels may cause differences in breast cancer risk
Researchers set benchmarks for screening mammography
Raloxifene Reduces Breast Cancer Risk in Postmenopausal Women at All Risk Levels
Physical activity improves survival in breast cancer patients
Pedigree assessment tool correctly identifies women with higher risk of breast cancer
MRI more accurately determines cancer spread into breast ducts
Core needle biopsy gives an accurate picture of gene expression


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us